STMN2 and amyotrophic lateral sclerosis: The attenuation of STMN2 expression, previously identified as a potential pathological indicator of TDP-43 mislocalization (to the cytoplasm rather than the nucleus) (Prudencio et al, 2020), was apparent in the ALS samples of the RNA-seq data set (Appendix Fig. S7C), suggestive of TDP-43 pathology.